CAS: 1239600-18-0

LMT-28 is an antimicrobial peptide, which is derived from natural amino acid sequences with potent bactericidal effects. This peptide functions by integrating into bacterial membranes, disrupting their integrity, and ultimately leading to cell lysis. The mechanism of action involves targeting the phospholipid bilayer of pathogenic microorganisms, thereby inducing membrane permeability and causing cell death. LMT-28 has promising applications in various scientific and medical fields, particularly in treating antibiotic-resistant infections. Its unique mode of action makes it a valuable tool in developing new antimicrobial therapies. Additionally, it serves as a pivotal component in research aimed at understanding bacterial resistance mechanisms and designing novel peptide-based drugs. The versatile nature of LMT-28 also opens opportunities for its use in agriculture, where it may contribute to controlling plant pathogens and enhancing crop resilience.

LMT-28 is an inhibitor of IL-6 and selectively inhibits IL-6-induced phosphorylation of gp130, STAT3, and JAK2.

LMT-28